Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amidotrizoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amidotrizoate |
Inferred relationship |
Some |
1 |
diatrizoat 30 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 58 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % steril opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Diatrizoate meglumine 30% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Diatrizoate meglumine 60% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Diatrizoate meglumine 18% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Diatrizoate meglumine 300mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 520 mg + diatrizoatnatrium 80 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 527 mg + iodipamidmeglumin 268 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Sodium amidotrizoate |
Is a |
True |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 180 mg + iod 85 mg/ml (18 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 2000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 30 % injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 30 % injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 58 % injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, ampul a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
diatrizoat 76 % injektionsvæske, opløsning, ampul a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amidotrizoate |
Inferred relationship |
Some |
|
Meglumine amidotrizoate |
Is a |
True |
Amidotrizoate |
Inferred relationship |
Some |
|
Amidotrizoic acid |
Is a |
True |
Amidotrizoate |
Inferred relationship |
Some |
|
Amidotrizoate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amidotrizoate |
Inferred relationship |
Some |
1 |